Cardiogenesis and the complex biology of regenerative cardiovascular medicine

Kenneth R Chien1, Ibrahim J Domian, Kevin Kit Parker

  • 1MGH Cardiovascular Research Center, Massachusetts General Hospital, Boston, MA 02114, USA. kchien@partners.org

Science (New York, N.Y.)
|December 6, 2008
PubMed

Insights

Understanding cardiac progenitor cells is key to heart development. Research into these cells and tissue engineering offers new avenues for regenerative cardiovascular medicine and disease modeling.

Area of Science:

  • Developmental Biology
  • Cell Biology
  • Regenerative Medicine

Background:

  • The heart comprises diverse muscle and nonmuscle cells, requiring complex formation and assembly processes.
  • Multipotent cardiac progenitor cells are crucial for building heart structures like muscle tissue, conduction systems, and vasculature.
  • These progenitors rely on external signaling cues for growth, differentiation, and integration.

Purpose of the Study:

  • To investigate the developmental pathways governing heart formation.
  • To explore the role of cardiac progenitor cells in cardiogenesis.
  • To assess the potential of tissue engineering and progenitor biology in cardiovascular medicine.

Main Methods:

  • Studying the biological complexity of in vivo cardiogenesis.
  • Identifying and characterizing multipotent cardiac progenitor cells.
  • Investigating non-cell-autonomous signaling pathways influencing progenitor behavior.

Main Results:

  • A family of multipotent cardiac progenitor cells has been identified.
  • These cells require external signals to expand, differentiate, and integrate into cardiac structures.
  • The study highlights the intricate cellular processes during heart development.

Conclusions:

  • Understanding cardiac progenitor cell behavior is fundamental to developmental biology.
  • Tissue-engineering technologies combined with patient-specific progenitor biology show promise for disease modeling.
  • This research may pave the way for novel regenerative cardiovascular medicine strategies.

Related Concept Videos

Regulation of the Cardiovascular System01:27

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Physiology of the Heart: The Cardiac Cycle01:18

Physiology of the Heart: The Cardiac Cycle

The cardiac cycle describes the events from one heartbeat to the next. It includes three main phases: diastole, atrial systole, and ventricular systole, all driven by changes in chamber pressures and the function of heart valves.
Diastole: The Relaxation Phase
During diastole, all four heart chambers relax. The atrioventricular (AV) valves open, and the semilunar valves close. This phase sees the lowest chamber pressures, promoting ventricular filling. Venous blood enters the heart through the...
Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart tube by...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...